RMCP better price value than UNIS

Picked By AMPSTOCKS
Picked: July 1, 2011 12:58:35 PM PDT
Rating

Revolutions Medical Corporation (Pink Sheets: RMCP) - Open

Symbol Position Allocation Picked Current Price
RMCP Long 10% $0.2600 $0.2600 0.00%


Opened July 1, 2011 12:58:35 PM PDT
Closed -
Risk High
Target Date -
Target Price $2.5000
Timeframe Mid-Term
Suggested Stop Loss -
Holding Long Position
Disclosure
This stock profile should be viewed as a paid advertisement, to enhance the public awareness of Revolutions Medical Corporation . and its securities through the distribution on this report. Acorn Management Partners LLC. has been paid by the company. Acorn Management Partners, LLC is an Investor Relations firm located in Alpharetta, Georgia, New York City, New York and London, UK. that specializes in bringing together management of publicly traded companies to investment management firms to provide attractive value opportunities. Statements made in this Report which are not purely historical are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and business of Revolutions Medical Corporation including, without limitation, (i) their ability to successfully implement the business plan and their ability to retain relationships with dealers, underwriters, suppliers, individual representatives and/or government agencies; and (ii) statements preceded by, followed by or that include the words “may”, “would”, “could”, “should”, “expects”, “projects”, “anticipates”, “believes”, “estimates”, “plans”, “intends”, “targets” or similar expressions. Our goal is to highlight specialized growth companies that are typically overlooked by the Wall Street community. Acorn Management can be found on the World Wide Web at www.fullmarketawareness.com Forward-looking statements speak only as of the date they are made. Revolutions Medical Corporation and the editor of this report do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements. This report was produced from information provided by the company or otherwise available in publicly available resources. The information herein is believed to be reliable but is not warranted as such. You should perform your own due diligence to verify any material information presented herein. This report is not a recommendation to buy or sell any securities. Any decision to buy or sell securities should be made only after consultation with the appropriate financial advisors. Investing in penny stocks carries inherent risk and you could lose all of your investment capital. Please refer to www.sec.gov for additional information on investing in penny stocks.

The Company recently placed its first order for 2.5 million 3ml RevVac™ Auto Retractable Vacuum Safety Syringes (the "RevVac™ Safety Syringe"). This initial order will begin to fulfill commitments made to distributors since the introduction of the RevVac™ Safety Syringe during the November 2010 Medica Conference in Dusseldorf, Germany. The Company anticipates this order to be shipped and delivered during the current quarter of 2011.

"The Company has reached a significant milestone by placing an initial order for our RevVac™ Safety Syringe and finally bringing it to the marketplace. I am very proud to have what I feel is the best safety syringe in the world now available to health care workers" states Ron Wheet, CEO and Chairman, Revolutions Medical Corporation.

Yahoo! Google Digg Facebook Del.ico.us Friendster Twitter LinkedIn StumbleUpon Reddit Newsvine FriendFeed Netvibes Tumblr Mister Wong WebNews Squidoo Diigo Blinklist Folkd Netvouz
Rate It : 1 2 3 4 5
Comments (0 Total)

View Counter
Bookmark and Share
Join the 200,000+ other Members who take full advantage of all the SmallCap Network has to offer: Sign In or Join